Clinical Practice

Use the tool below to view all available Rheumatology Academy Series

Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living Rheum
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
- Gary S. Firestein, MD
Sjögren’s Disease Management: A Decade in Review
Sjögren’s Disease Management: A Decade in Review
Living Rheum
Sjögren’s Disease Management: A Decade in Review
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
Living Rheum
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
Sjögren’s Disease Care: Diagnosis and Management Considerations
Sjögren’s Disease Care: Diagnosis and Management Considerations
Living Rheum
Sjögren’s Disease Care: Diagnosis and Management Considerations
- Nancy Carteron, MD
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
Living Rheum
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
- Nancy Carteron, MD
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
Living Rheum
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
- Nancy Carteron, MD
Advances in Osteoporosis Treatment: Exploring Drug and Non-Drug Interventions
Advances in Osteoporosis Treatment: Exploring Drug and Non-Drug Interventions
On the Frontlines of Osteoporosis
Advances in Osteoporosis Treatment: Exploring Drug and Non-Drug Interventions
- Ashley Baker, MSN, PMHNP
- Jad Sfeir, MD, MS
Managing High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
Managing High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
On the Frontlines of Osteoporosis
Managing High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
- Charles Turck, PharmD, BCPS, BCCCP
- Bart Clarke, MD
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Living Rheum
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
- Michelle Hessen, OD
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
Living Rheum
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
- Michelle Hessen, OD
Diagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
Diagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
Living Rheum
Diagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Living Rheum
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
- Ryan Quigley
Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
Living Rheum
Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
- Marlene Maeusli
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Living Rheum
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
On the Frontlines of Osteoporosis
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
- Ryan Quigley
- Charles Ginsberg, MD
Empowering Safer Movement: Fall Prevention Strategies for Osteoporosis Care
Empowering Safer Movement: Fall Prevention Strategies for Osteoporosis Care
On the Frontlines of Osteoporosis
Empowering Safer Movement: Fall Prevention Strategies for Osteoporosis Care
- Karen Kemmis, PT, DPT, MS, FAADE

Clinical Practice

Popular

CONTACT US

(866) 423-7849

CONTACT US

(866) 423-7849

Clinical Practice

Popular

Title

Share on ReachMD